PSC Support update
Molecular Signatures Identified to Predict Primary Sclerosing Cholangitis Progression and Cancer Risk
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
Read MorePSC-IBD Bowel Cancer Risk Study Shows Promising Findings
New PSC-IBD research from Dr Chandni Radia suggests bowel cancer risk may be lower than previously thought, helping us build evidence to tailor future colonoscopy guidelines.
Read MorePromising Leap Forward in Research on PSC and Bile Duct Cancer
New research identifies a marker (COX2) linking lab models to real-world PSC patients, advancing early cancer detection efforts.
Read MoreMajor Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Major Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Read MoreResearch Update: New Clues to PSC Progression
Dr Anthony George shares new insights into immune cells and predicting PSC progression.
Read MoreNew PSC Support Research Uncovers Critical Link Between Liver and Small Intestine
PSC Support funding helps uncover new clues in the small intestine for potential new treatments for primary sclerosing cholangitis.
Read MorePSC Treatment Breakthroughs 2025
Discover the 2025 breakthroughs in PSC research and how they are shaping 2026.
Read MoreNov 2025 Research Roundup
Our November roundup features encouraging Phase II trial updates, new gut-liver research, and UK policy changes to speed up rare disease treatment access.
Read MoreTime to Talk About Bile Duct Cancer Risk in PSC
Patient survey results shared at major liver conference.
Read MoreOct 2025 Research Roundup
A look at our recent visit to Belfast for the BASL conference and Information Day
Read More